237 related articles for article (PubMed ID: 32294141)
1. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
[TBL] [Abstract][Full Text] [Related]
2. Identification of a homology-independent linchpin domain controlling mouse and bank vole prion protein conversion.
Burke CM; Mark KMK; Walsh DJ; Noble GP; Steele AD; Diack AB; Manson JC; Watts JC; Supattapone S
PLoS Pathog; 2020 Sep; 16(9):e1008875. PubMed ID: 32898162
[TBL] [Abstract][Full Text] [Related]
3. Full restoration of specific infectivity and strain properties from pure mammalian prion protein.
Burke CM; Walsh DJ; Steele AD; Agrimi U; Di Bari MA; Watts JC; Supattapone S
PLoS Pathog; 2019 Mar; 15(3):e1007662. PubMed ID: 30908557
[TBL] [Abstract][Full Text] [Related]
4. The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro.
Nishina KA; Deleault NR; Mahal SP; Baskakov I; Luhrs T; Riek R; Supattapone S
Biochemistry; 2006 Nov; 45(47):14129-39. PubMed ID: 17115708
[TBL] [Abstract][Full Text] [Related]
5. Efficient interspecies transmission of synthetic prions.
Block AJ; Shikiya RA; Eckland TE; Kincaid AE; Walters RW; Ma J; Bartz JC
PLoS Pathog; 2021 Jul; 17(7):e1009765. PubMed ID: 34260664
[TBL] [Abstract][Full Text] [Related]
6. Non-genetic propagation of strain-specific properties of scrapie prion protein.
Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
[TBL] [Abstract][Full Text] [Related]
7. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
8. PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
Khalili-Shirazi A; Summers L; Linehan J; Mallinson G; Anstee D; Hawke S; Jackson GS; Collinge J
J Gen Virol; 2005 Sep; 86(Pt 9):2635-2644. PubMed ID: 16099923
[TBL] [Abstract][Full Text] [Related]
9. A receptor for infectious and cellular prion protein.
Martins VR
Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid cofactor solubilization inhibits formation of native prions.
Schwind AM; Walsh DJ; Burke CM; Supattapone S
J Neurochem; 2023 Sep; 166(5):875-884. PubMed ID: 37551010
[TBL] [Abstract][Full Text] [Related]
11. Prion disease tempo determined by host-dependent substrate reduction.
Mays CE; Kim C; Haldiman T; van der Merwe J; Lau A; Yang J; Grams J; Di Bari MA; Nonno R; Telling GC; Kong Q; Langeveld J; McKenzie D; Westaway D; Safar JG
J Clin Invest; 2014 Feb; 124(2):847-58. PubMed ID: 24430187
[TBL] [Abstract][Full Text] [Related]
12. Copper and Zinc Interactions with Cellular Prion Proteins Change Solubility of Full-Length Glycosylated Isoforms and Induce the Occurrence of Heterogeneous Phenotypes.
Brim S; Groschup MH; Kuczius T
PLoS One; 2016; 11(4):e0153931. PubMed ID: 27093554
[TBL] [Abstract][Full Text] [Related]
13. Conformational diversity in purified prions produced in vitro.
Walsh DJ; Schwind AM; Noble GP; Supattapone S
PLoS Pathog; 2023 Jan; 19(1):e1011083. PubMed ID: 36626391
[TBL] [Abstract][Full Text] [Related]
14. Prions amplify through degradation of the VPS10P sorting receptor sortilin.
Uchiyama K; Tomita M; Yano M; Chida J; Hara H; Das NR; Nykjaer A; Sakaguchi S
PLoS Pathog; 2017 Jun; 13(6):e1006470. PubMed ID: 28665987
[TBL] [Abstract][Full Text] [Related]
15. A Structural and Functional Comparison Between Infectious and Non-Infectious Autocatalytic Recombinant PrP Conformers.
Noble GP; Wang DW; Walsh DJ; Barone JR; Miller MB; Nishina KA; Li S; Supattapone S
PLoS Pathog; 2015 Jun; 11(6):e1005017. PubMed ID: 26125623
[TBL] [Abstract][Full Text] [Related]
16. Prion replication environment defines the fate of prion strain adaptation.
Katorcha E; Gonzalez-Montalban N; Makarava N; Kovacs GG; Baskakov IV
PLoS Pathog; 2018 Jun; 14(6):e1007093. PubMed ID: 29928047
[TBL] [Abstract][Full Text] [Related]
17. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
[TBL] [Abstract][Full Text] [Related]
18. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
Katorcha E; Makarava N; Savtchenko R; Baskakov IV
Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
[TBL] [Abstract][Full Text] [Related]
19. Reversible unfolding of infectious prion assemblies reveals the existence of an oligomeric elementary brick.
Igel-Egalon A; Moudjou M; Martin D; Busley A; Knäpple T; Herzog L; Reine F; Lepejova N; Richard CA; Béringue V; Rezaei H
PLoS Pathog; 2017 Sep; 13(9):e1006557. PubMed ID: 28880932
[TBL] [Abstract][Full Text] [Related]
20. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
